Revenue - Maat Pharma SA (PAR:MAAT) - Alpha Spread
M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.3 EUR 2.24% Market Closed
Market Cap: 101.4m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maat Pharma SA
Revenue Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Revenue
€2.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Revenue
€221.6m
CAGR 3-Years
26%
CAGR 5-Years
15%
CAGR 10-Years
20%
Nanobiotix SA
PAR:NANO
Revenue
€30.1m
CAGR 3-Years
744%
CAGR 5-Years
204%
CAGR 10-Years
67%
Innate Pharma SA
PAR:IPH
Revenue
€24.9m
CAGR 3-Years
-10%
CAGR 5-Years
-26%
CAGR 10-Years
11%
Genfit SA
NASDAQ:GNFT
Revenue
€38.2m
CAGR 3-Years
70%
CAGR 5-Years
38%
CAGR 10-Years
20%
Eurobio Scientific SA
PAR:ALERS
Revenue
€130m
CAGR 3-Years
-12%
CAGR 5-Years
21%
CAGR 10-Years
16%

See Also

What is Maat Pharma SA's Revenue?
Revenue
2.2m EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Revenue amounts to 2.2m EUR.

What is Maat Pharma SA's Revenue growth rate?
Revenue CAGR 1Y
56%

Over the last year, the Revenue growth was 56%.

Back to Top